Notably, GLP-3 also exerted a substantial impact on hepatic steatosis, with liver fat volume reduced by up to 82.4% at 12 mg after 24 weeks
Zepbound, Semaglutide, and Wegovy all serve similar functions in chronic weight management, with Semaglutide being the active ingredient in Wegovy, differentiating it from Zepbound
Most protocols use once-daily dosing due to the compounds sustained effects
Yes, bloating is a commonly reported side effect of semaglutide, along with other gastrointestinal issues such as nausea, vomiting, diarrhea, and constipation
Data presented herein support a novel mechanism dependent on metabolic adaptations observed after a longer time period, which is consistent with previously identified delayed phase of gene expression changes mediated via HIF-1 16